Wegovy fuels sharp rise in use of weight-loss drugs for US youth
Posted on AllSides February 15th, 2024
From The Center
A small but rapidly growing number of U.S. adolescents began treatment with Novo Nordisk's <NOVOb.CO> weight-loss drug Wegovy last year, a powerful new tool to address record rates of pediatric obesity, according to data shared exclusively with Reuters.